<DOC>
	<DOCNO>NCT01871363</DOCNO>
	<brief_summary>Pathological complete response , ( pCR ) correlate favourable overall prognosis locally advanced rectal cancer patient underwent preoperative chemoradiation , obtain pCR might beneficial . The aim study investigate safety efficacy preoperative IMRT combine bevacizumab capecitabine . primary endpoint pathological complete remission rate .</brief_summary>
	<brief_title>Phase II Study Preoperative IMRT Combined With Capecitabine Bevacizumab Locally Advanced Rectal Cancer</brief_title>
	<detailed_description />
	<mesh_term>Rectal Neoplasms</mesh_term>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<criteria>Male female patient histologically proven adenocarcinoma rectum , T3/4 node positive disease ( clinical stage accord TNM classification system ) No evidence metastatic disease . Age 18 65 year Kps 80100 No prior radiotherapy , chemotherapy target therapy rectal cancer Normal hematological , hepatic renal function , Ability swallow tablet Signed informed consent Patients must willing able comply protocol duration study Malignancy rectum adenocarcinoma Other coexist malignancy malignancy within past 5 year , exception adequately treat situ carcinoma cervix basal cell carcinoma skin Significant heart disease ( uncontrolled hypertension despite medication ( &gt; 150/100 mmHg ) , NYHA class III IV heart disease , unstable angina myocardial infarction within past 1 year prior study entry , history significant ventricular arrhythmia require treatment ) Evidence active peptic ulcer upper GI bleed Evidence bleed diathesis coagulopathy Patients receive concomitant treatment drug interact capecitabine flucitosine , phenytoin , warfarin Known hypersensitivity biological drug Treatment investigational drug within 30 day begin treatment study drug Pregnant lactating patient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Preoperative Chemoradiotherapy</keyword>
	<keyword>Bevacizumab</keyword>
	<keyword>Locally Advanced Rectal Cancer</keyword>
</DOC>